Tetra-triethyleneoxysulfonyl substituted zinc phthalocyanine for photodynamic cancer therapy
- 7 July 2015
- journal article
- review article
- Published by Elsevier BV in Photodiagnosis and Photodynamic Therapy
- Vol. 13, 148-157
- https://doi.org/10.1016/j.pdpdt.2015.07.001
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- A set of highly water-soluble tetraethyleneglycol-substituted Zn(ii) phthalocyanines: synthesis, photochemical and photophysical properties, interaction with plasma proteins and in vitro phototoxicityDalton Transactions, 2010
- Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumoursBritish Journal of Cancer, 2010
- Long-term exposure of CdTe quantum dots on PC12 cellular activity and the determination of optimum non-toxic concentrations for biological useJournal of Nanobiotechnology, 2010
- Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell CarcinomasClinical Cancer Research, 2008
- Photodynamic activity of BAM-SiPc, an unsymmetrical bisamino silicon(IV) phthalocyanine, in tumour-bearing nude miceBritish Journal of Pharmacology, 2008
- Synthesis and photodynamic potential of tetra- and octa-triethyleneoxysulfonyl substituted zinc phthalocyaninesJournal of Photochemistry and Photobiology A: Chemistry, 2007
- Targeting the epidermal growth factor receptor by erlotinib (Tarceva™) for the treatment of esophageal cancerInternational Journal of Cancer, 2005
- Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinomaJournal of Hepatology, 2004
- Photodynamic therapeutics: basic principles and clinical applicationsDrug Discovery Today, 1999